Skip to content

Episode 263: Christine Ann Miller believes boards need diversity of skills and life experiences to help them thrive

Subscribe to the Take on Board podcast through Apple Podcasts or your favourite podcast app. I would love it if you would share this episode with a friend who might be interested. Ratings and reviews are also welcome.

Or, listen to episode 263 here

Shownotes

Today on the Take on Board podcast I’m speaking with Christine Miller about diversity in the boardroom.

Christine is on the boards of Advisory boards on: BioNJ, Antimicrobials Working Group, HBA. She has previously been on the boards of Iveric Bio.

Christine Miller is currently the President and CEO of Melinta Therapeutics, where she is accelerating transformation, and redefining the portfolio from pure play antibiotics to become a leader in the acute care space. Christine loves working in the healthcare space. She says: “The potential to drive innovation and transformation for companies, teams, stakeholders and patients – is the compass that guides my purpose. But a leader’s job is more than driving innovation – it’s about making sure there is honesty and meaning behind your purpose to ensure you’re always doing the right thing at the right time, no matter how hard things get.”

Also mentioned this episode:

You can find Christine on:

Resources Christine mentions:

Professional headshot photograph of Christine Ann Miller

Subscribe to the Take on Board podcast

You might want to:

Share this

Archives

Tags